Statin therapy reduces the risk of ventricular arrhythmias, sudden cardiac death, and mortality in heart failure patients: A nationwide population-based cohort study

the drug. Therefore, one should always have in mind that during treatment of systemic inflammatory, neoplastic or hematological diseases with monoclonal antibodies the production of anti-drug antibodies is a reality. These antibodies can cause hypersensitivity reactions, worsen overt or incipient heart failure [11] and induce myocardial infarction manifesting as Kounis syndrome [3]. The authors of this manuscript have certified that they comply with the Principles of Ethical Publishing in the International Journal of Cardiology.